Teva Pharmaceutical Industries Ltd (TEVA.TA) will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic.

The settlement with New York adds an additional $300 million to Teva's total opioid payouts. Teva is working to finalize a nationwide settlement valued at more than $4.2 billion, and New York was already slated to receive cash and medication as part of that deal.

"You cannot put a price on lives lost, addiction suffered, and families torn apart, but with the more than $2 billion we have now delivered to New Yorkers, we can continue to rebuild and recover," New York Attorney General Letitia James said on Thursday, referring also to opioid settlements with other companies.